NCT01054079View on ClinicalTrials.gov

Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
Interventions
OTHER

laboratory biomarker analysis

Correlative study

PROCEDURE

quality-of-life assessment

Ancillary study

OTHER

questionnaire administration

Ancillary study

DRUG

cinacalcet hydrochloride

Given PO

Trial Locations (1)

27157

Wake Forest University Health Sciences, Winston-Salem

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Wake Forest University Health Sciences

OTHER

NCT01054079 - Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer | Biotech Hunter | Biotech Hunter